Form 4: SANUWAVE Health Director Gregory Bazar Acquires 1,574 Fully Vested Stock Options

SANUWAVE Health, Inc. Director Gregory Matthew Bazar was granted 1,574 stock options, which were fully vested at the grant date, with an exercise price of $32.86.

Summary

• Gregory Matthew Bazar, a Director of SANUWAVE Health, Inc. (SNWV), acquired 1,574 derivative securities in the form of stock options.
• The transaction date for this acquisition was June 30, 2025.
• Each stock option has an exercise price of $32.86.
• The options were fully vested at the grant date, June 30, 2025.
• The expiration date for these stock options is June 30, 2030.
• Each option represents the right to buy one share of SANUWAVE Health, Inc. Common Stock.
• Following this transaction, Gregory Matthew Bazar beneficially owns 1,574 derivative securities directly.

Sentiment

Score: 7

Explanation: The grant of fully vested stock options to a director is generally a positive signal, indicating alignment of interests and confidence in the company's future performance.

Positives

• The acquisition of stock options by a director indicates an increased alignment of management's interests with those of shareholders.
• The options were fully vested at the grant date, meaning the director immediately gains the right to exercise them, reflecting immediate value and commitment.

Future Outlook

The document does not provide forward-looking statements or guidance beyond the expiration date of the granted options.

Industry Context

This Form 4 filing reflects a standard equity compensation event for a director in a publicly traded company, common across various industries to align executive and board interests with shareholder value.

Related Party Transactions

• The grant of stock options to Gregory Matthew Bazar, a Director of SANUWAVE Health, Inc., constitutes a related party transaction as it involves a transaction between the company and a member of its board.

Stakeholder Impact

• Shareholders: The grant of stock options to a director aligns their financial interests with those of the shareholders, potentially incentivizing decisions that enhance long-term shareholder value.

Next Steps

• The director may choose to exercise these options at any time between the grant date and the expiration date, subject to market conditions and personal financial planning.

Key Dates

Keywords

SANUWAVE Health, SNWV, stock options, insider transaction, director, equity compensation, Form 4, SEC filing